⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

AMGN

Amgen Inc.

Healthcare · Drug Manufacturers - General

439.26USD

-8.0200 (-1.79%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on AMGN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 439.26
P/E27.2
Dvd Ind Yld2.3%
P/B20.32
P/S6.2
Curr EV/T12M EBITDA19.9
Mkt Cap (USD)237.5B
Curr EV (USD)280.8B
2)

Per Share Data

EPS T12M16.10
DPS9.72
Bk Val Per Sh21.62
Rev/Sh70.03
Cash/Sh25.88
Curr Shares Out540.6M
FCF/Sh18.70
3)

Cash Flow Analysis

P/CF19.0
Curr P/FCF23.3
CF/NI1.4
Dvd P/O60.4%
Cash Gen/Cash Reqd1.6
Csh Dvd Cov2.4
CFO/Sales32.8%
Eff Interest Rate4.7%
4)

Growth Potential

Dil EPS 1Y Gr88.2%
Cap 1Y Gr-4.1%
BPS 1Y Gr47.0%
R&D To Sales—
Retention Rate39.6%
Rev 1Y Gr10.0%
FCF 1Y Gr-22.1%
Assets 1Y Gr-1.4%
5)

Profitability

EBITDA14.1B
EBIT11.4B
Operating Margin30.0%
Pretax Margin27.0%
Net Margin23.0%
ROA9.5%
ROE91.5%
ROC14.1%
Asset Turnover0.42
6)

Structure

Current Ratio1.37
Quick Ratio0.95
Debt/Assets59.9%
Debt/Com Eq490.3%
Net Debt/EBITDA3.07
Tot Debt/Capital83.1%
Gross Margin69.5%
EBIT/Int Exp4.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.